Since January 31st, Coronavirus has spread along all the Spanish territory; however, some regions are particularly compromised in terms of number of cases: Madrid, Catalonia, Basque Country and the two Castillian regions. The total number of confirmed cases is about to surpass Italy. We hope to be reaching the plateau of the curve, after all the implemented social distancing measures.

During an extraordinary virtual meeting held on 2 April 2020, EMA’s human medicines committee (CHMP) gave recommendations on how the investigational antiviral medicine remdesivir should be used for treating coronavirus disease (COVID-19) in compassionate use programmes in the European Union.

The European Reference Netowrk for Epilepsy (EpiCARE) will hold a special webinar on Tuesday, April 7 with experts from Spain and Italy on the change to epilepsy care due to the COVID-19 pandemic.

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus causes a pneumonia syndrome, with specific and already well-described symptoms, and fatal outcome in a subset of patients. The lungs are… Continue Reading

Tim J von Oertzen, Ronan McGinty, Martin Holtkamp, Reetta Kalviainen, Stephan Ruegg, Eugen Trinka, Guido Rubboli 3rd April 2020 Physicians of all specialties worldwide are challenged by the new SARS-CoV-2 virus causing corona virus disease 2019 (COVID-19). The virus is… Continue Reading

During the Covid-19 pandemic, most European countries have imposed personal restrictions on their populations in order to inhibit viral transmission and spread of infection. The hardest restriction concerns the imposition not to leave home unless to go to the supermarket,… Continue Reading

Recently released guidance on stroke management during the current COVID-19 pandemic emphasises carefully managed triage, importance of appropriate personal protective equipment, and crisis resource management.

by Ettore Beghi & Daniel Berekzcki An unexpected outbreak due to the infection by the coronavirus, Covid-19, which started in China at the end of 2019, is rapidly expanding and is now officially assigned pandemic status by the WHO. After… Continue Reading

Prof. Claudio Bassetti, President of the EAN and Prof. Mohamed Al-Shehab, President of the PAUNS are pleased to announce that: EAN signed a Memorandum of Understanding with PAUNS – Pan Arab Union of Neurological Societies joining forces to promote optimal… Continue Reading

The World Muslcle Society has recently published its position and advice on the COVID-19 and people with neuromuscular disorders.

Covid-19 has affected over 500,000 people and caused over 21,000 deaths. People from all over the world are making great sacrifices, from social distancing to sustaining economic loss. Healthcare workers are on the frontline, and neurologists are increasingly involved as well.

In these troubled times, our Paper of the Month for April is: Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the Covid-19 outbreak in Lombardy, Italy: Early experience and forecast during an emergency response.

As the number of COVID-19 cases continues to rise in the majority of European Countries, including Italy, neurologists should prepare to manage these cases. As already known, preparation has been challenged by rapidly changing guidelines, inconsistent directives, and a lack of testing capability.

24. March 2020 Corona Virus Disease 2019 (COVID-19) is a new illness caused by the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which typically causes fever, cough, respiratory symptoms, diarrhea, reduction of smell and taste sensation and may… Continue Reading